hVIVO plc CRO.F Stock
hVIVO plc Price Chart
hVIVO plc CRO.F Financial and Trading Overview
| hVIVO plc stock price | 0.3 EUR |
| Previous Close | 0.18 EUR |
| Open | 0.18 EUR |
| Bid | 0.17 EUR x N/A |
| Ask | 0.2 EUR x N/A |
| Day's Range | 0.18 - 0.18 EUR |
| 52 Week Range | 0.08 - 0.24 EUR |
| Volume | 10K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 137.98M EUR |
| Beta (5Y Monthly) | 1.099589 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.03 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | May 4, 2023 |
| 1y Target Est | N/A |
CRO.F Valuation Measures
| Enterprise Value | 93.89M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.7216039 |
| Price/Book (mrq) | 5.966667 |
| Enterprise Value/Revenue | 1.852 |
| Enterprise Value/EBITDA | 13.336 |
Trading Information
hVIVO plc Stock Price History
| Beta (5Y Monthly) | 1.099589 |
| 52-Week Change | 48.76% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.24 EUR |
| 52 Week Low | 0.08 EUR |
| 50-Day Moving Average | 0.17 EUR |
| 200-Day Moving Average | 0.14 EUR |
CRO.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 678.76M |
| Float | 609.45M |
| Short Ratio | N/A |
| % Held by Insiders | 43.90% |
| % Held by Institutions | 10.06% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -1.53% |
| Operating Margin (ttm) | 12.11% |
| Gross Margin | 17.89% |
| EBITDA Margin | 13.88% |
Management Effectiveness
| Return on Assets (ttm) | 8.19% |
| Return on Equity (ttm) | -3.79% |
Income Statement
| Revenue (ttm) | 50.7M EUR |
| Revenue Per Share (ttm) | 0.08 EUR |
| Quarterly Revenue Growth (yoy) | 100.89% |
| Gross Profit (ttm) | 9.07M EUR |
| EBITDA | 7.04M EUR |
| Net Income Avi to Common (ttm) | -776000 EUR |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 28.44M EUR |
| Total Cash Per Share (mrq) | 0.04 EUR |
| Total Debt (mrq) | 1.56M EUR |
| Total Debt/Equity (mrq) | 7.73 EUR |
| Current Ratio (mrq) | 1.419 |
| Book Value Per Share (mrq) | 0.03 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 15.98M EUR |
| Levered Free Cash Flow (ttm) | 11.99M EUR |
Profile of hVIVO plc
| Country | Germany |
| State | N/A |
| City | London |
| Address | 21 Plumbers Row |
| ZIP | E1 1EQ |
| Phone | 44 20 7756 1300 |
| Website | https://www.hvivo.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 210 |
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing of vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, it offers specialized virology and immunology laboratory, which offers a suite of services to support pre-clinical and clinical respiratory drug; and vaccine discovery and development. Further, the company provides preclinical and early clinical research services; sales and marketing services; data management; and statistics services, as well as drug development consultancy and services. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
Q&A For hVIVO plc Stock
What is a current CRO.F stock price?
hVIVO plc CRO.F stock price today per share is 0.3 EUR.
How to purchase hVIVO plc stock?
You can buy CRO.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for hVIVO plc?
The stock symbol or ticker of hVIVO plc is CRO.F.
Which industry does the hVIVO plc company belong to?
The hVIVO plc industry is Biotechnology.
How many shares does hVIVO plc have in circulation?
The max supply of hVIVO plc shares is 713.1M.
What is hVIVO plc Price to Earnings Ratio (PE Ratio)?
hVIVO plc PE Ratio is 10.13333300 now.
What was hVIVO plc earnings per share over the trailing 12 months (TTM)?
hVIVO plc EPS is 0.03 EUR over the trailing 12 months.
Which sector does the hVIVO plc company belong to?
The hVIVO plc sector is Healthcare.